Document:

EX-10.1

 

Exhibit 10.1

EXECUTION COPY

FOURTH OMNIBUS AMENDMENT

(Apple Ridge)

     THIS Fourth Omnibus Amendment (this “Agreement”) is entered into this 29th day of
November, 2006 for the purpose of making amendments to the documents described in this Agreement.

     WHEREAS, this Agreement is among (i) Cartus Corporation, a Delaware corporation
(“Cartus”), (ii) Cartus Financial Corporation, a Delaware Corporation (“CFC”),
(iii) Apple Ridge Services Corporation, a Delaware corporation (“ARSC”), (iv) Apple Ridge
Funding LLC, a limited liability company organized under the laws of the State of Delaware (the
“Issuer”), (v) The Bank of New York, as successor to JPMorgan Chase Bank, N.A., a banking
corporation organized and existing under the laws of New York, as successor Indenture Trustee. (the
“Indenture Trustee”), (vi) The Bank of New York, a New York state banking corporation (the
“Paying Agent”), as paying agent, authentication agent and transfer agent and registrar,
(vii) the Conduit Purchasers, Committed Purchasers and Managing Agents party to the Note Purchase
Agreement defined below, and (viii) Calyon Corporate and Investment Bank, as Administrative Agent
and Lead Arranger (the “Administrative Agent”).

     WHEREAS, this Agreement relates to the following documents (as such documents have previously
been amended):

          —Master Indenture dated as of April 25, 2000 (the “Master Indenture”) among
the Issuer, the Indenture Trustee and the Paying Agent.

          —Transfer and Servicing Agreement dated as of April 25, 2000 (the “Transfer and
Servicing Agreement”) by and between ARSC, as transferor, Cartus, as originator and
servicer, CFC, as originator, the Issuer, as transferee and the Indenture Trustee;

          —Indenture Supplement dated as of January 31, 2005 (the “Indenture
Supplement”) among the Issuer, the Indenture Trustee and the Paying Agent;

          —Note Purchase Agreement dated as of January 31, 2005 (the “Note Purchase
Agreement”) among the Issuer, Cartus, as servicer, the Conduit Purchasers, Committed
Purchasers and Managing Agents party thereto, and the Administrative Agent; and

     WHEREAS, the Transfer and Servicing Agreement, Indenture Supplement and the Note Purchase
Agreement are, in this Agreement, collectively the “Affected Documents”;

     WHEREAS, terms used in this Agreement and not defined herein shall have the meanings assigned
to such terms in the Purchase Agreement, and, if not defined therein, as defined in the Master
Indenture.

 

 

     NOW, THEREFORE, the parties hereto hereby recognize and agree:

	1.	 	Effective as of the date hereof, the Note Purchase Agreement is hereby amended as
follows:

	 	a.	 	Section 1.01 is hereby amended to delete the definition of “Commitment
Termination Date” in its entirety and to substitute therefor the following
definition of “Commitment Termination Date”:
	 
	 	 	 	“Commitment Termination Date” means November 27, 2007, or such later
date to which the Termination Date may be extended in accordance with Section 2.11
of this Agreement.”
	 
	 	b.	 	Schedule II is hereby amended to delete in its entirety and to
substitute therefor the following:

SCHEDULE II

PURCHASER GROUP INFORMATION

	 	 	 	 	 	 	 	 	 	 	 	 	 
	Managing Agent	 	Conduit Purchaser(s)	 	Committed Purchaser(s)	 	Commitment(s)	 	Purchaser Group Limit
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	CALYON Corporate
and Investment Bank

	 	Atlantic Asset
Securitization
Corp.
	 	Calyon New York Branch
	 	$	206,818,182	 	 	$	206,818,182	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	BMO Capital Markets
Corp.

	 	Fairway Finance

Company, LLC
	 	The Bank of Montreal
	 	$	177,272,727	 	 	$	177,272,727	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	The Bank of
Tokyo-Mitsubishi
UFJ, Ltd., New York
Branch

	 	Victory Receivables

Corporation
	 	The Bank of
Tokyo-Mitsubishi UFJ,
Ltd., New York Branch
	 	$	118,181,818	 	 	$	118,181,818	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	The Bank of Nova
Scotia

	 	Liberty Street
Funding Corp.
	 	The Bank of Nova
Scotia
	 	$	147,727,273	 	 	$	147,727,273	 
	 
	 	 	 	 	 	 	 	 	 	 	 	 
	SMBC Securities,
Inc.

	 	Manhattan Asset

Funding Company LLC
	 	Sumitomo Mitsui

Banking Corporation
	 	$	50,000,000	 	 	$	50,000,000	 

	2.	 	Effective as of the date hereof, the Transfer and Servicing Agreement is hereby amended
as follows:

	 	a.	 	Section 1.01 is hereby amended to delete the definition of “Reported
EBITDA”.

2

 

	 	b.	 	Section 9.01 is hereby amended to delete clause (f) in its entirety and
to substitute therefor the following clause (f):
	 
	 	 	 	“Realogy shall fail to have a long-term unsecured debt rating of BB- or better from
Standard & Poors and Ba3 or better from Moody’s;”

	3.	 	Effective as of the date hereof, the Indenture Supplement is hereby amended as follows:

	 	a.	 	Section 6.01(j) is hereby amended to delete the figure “one hundred
fifty (150)” and to substitute therefor “one hundred eighty (180)”
	 
	 	b.	 	Section 6.01(k) is hereby amended to delete the figure “one hundred
twenty (120)” and to substitute therefor “one hundred fifty (150)”
	 
	 	c.	 	Section 2.01 is hereby amended to delete the definition of “Yield
Reserve Ratio” in its entirety and to substitute therefor the following definition
of “Yield Reserve Ratio”:
	 
	 	 	 	““Yield Reserve Ratio” shall mean, as of any date of determination, the
quotient expressed as a percentage, of (a) the product of (i) the sum of (A) the
product of (1) the Applicable Yield Factor multiplied by (2) the one-month
Eurodollar Rate as of the last Business Day of the immediately preceding Monthly
Period plus (B) 0.75% multiplied by (ii) 2.25 multiplied by the Average Days
Outstanding as of the end of the immediately preceding Monthly Period divided by (b)
360. For purposes of the foregoing, the “Applicable Yield Factor” shall be 1.25,
provided that if the Average Days in Inventory for Appraised Value
Homes for any Monthly Period is equal to or greater than one hundred fifty (150)
days, then commencing on such date the Applicable Yield Factor shall be 2.25 and
shall continue to be 2.25 until such time as the Average Days in Inventory for
Appraised Value Homes has been reduced to and remained below one hundred fifty (150)
days for two (2) consecutive Monthly Periods.”

	4.	 	Effective as of the date hereof, the Master Indenture is hereby amended as follows:

	 	a.	 	Obligor Limit: The definition of “Obligor Limit” is hereby
amended to add the following proviso at the end of the first sentence therein:
	 
	 	 	 	“, and provided, further, that notwithstanding the foregoing, with
respect to Accenture Ltd., so long as Accenture Ltd. has (i) an unsecured long-term
debt rating (or equivalent shadow rating) of “A+” or better from S&P and (ii) either
no unsecured long-term rating from Moody’s or an unsecured long-term rating of “A1”
or better from Moody’s, Accenture Ltd. shall have an Obligor Limit of 6% of the
Aggregate Receivable Balance.”

	5.	 	Conditions Precedent.

	 	a.	 	This Agreement shall be effective upon satisfaction of the following
conditions precedent: the Indenture Trustee shall have previously received (a)
counterparts of the signature pages hereto executed by all parties hereto, (b)
counterparts of the

3

 

	 	 	 	signature pages to the amended and restated Fee Letter (as
defined in the Indenture Supplement) executed by all parties thereto, (c) the
consent of the Majority Investors to the execution of this Agreement, which consent
shall be evidenced by their execution of the signature pages attached to this
Agreement, and (d) counterparts of an Assignment and Acceptance, executed by all of
the Purchasers party hereto confirms the information set forth in Section 1(a)
hereof.
	 
	 	b.	 	The Issuer shall have caused to be executed and delivered to The Bank
of New York, as authentication agent, (i) a Series 2005-1 Note in the amount of
$50,000,000 payable to the order of SMBC Securities, Inc., as Managing Agent for
its Purchaser Group, together with an Issuer Order requesting authentication of the
same and (ii) a Series 2005-1 Note payable to The Bank of Tokyo-Mitsubishi UFJ,
Ltd., New York Branch (“BTM”), as Managing Agent, in the amount of $118,181,818,
together with an Issuer Order requesting authentication of the same upon BTM’s
surrender to the Authentication Agent of its pre-existing Series 2005-1 Note. The
Issuer further agrees, upon request from any other Managing Agent, to execute and
deliver, and request the Authentication Agent to authenticate, a replacement Series
2005-1 Note payable to such Managing Agent in the amount of its new Purchaser Group
Limit upon surrender of such Managing Agent’s pre-existing Series 2005-1 Note.

	6.	 	THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE INTERNAL LAWS
OF THE STATE OF NEW YORK, INCLUDING §5-1401 OF THE NEW YORK GENERAL OBLIGATIONS LAW, BUT
OTHERWISE WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES.

	7.	 	This Agreement may be executed in any number of counterparts and by different parties
hereto in separate counterparts, each of which when so executed shall be deemed to be an
original and all of which when taken together shall constitute one and the same agreement.

	8.	 	Upon the effectiveness of this Agreement: (i) all references in any Affected Document
to “this Agreement”, “hereof”, “herein” or words of similar effect referring to such
Affected Document shall be deemed to be references to such Affected Document as amended by
this Agreement; (ii) each reference in any of the Affected Documents to any other Affected
Document and each reference in any of the other Transaction Documents to any of the
Affected Documents shall each mean and be a reference to such Affected Document as amended
by this Agreement; and (iii) each reference in any Transaction Document to any of the terms
or provisions of an Affected Document which are redefined or otherwise modified hereby
shall mean and be a reference to such terms or provisions as redefined or otherwise
modified by this Agreement; provided, that, notwithstanding the foregoing or any
other provisions of this Agreement , the amendments contained in this Agreement shall not
be effective
to (x) modify on a retroactive basis any representations or warranties previously made
under the Purchase Agreement, Receivables Purchase Agreement or Transfer and Servicing
Agreement with respect to Receivables transferred or purported to have

4

 

	 	 	been transferred
thereunder prior to the date herein, which representations and warranties shall continue
to speak as of the dates such Receivables were transferred and based on the terms and
provisions of the Affected Documents as in effect at such time or (y) otherwise modify
the terms of any transfer or purported transfer of any Receivable transferred or
purported to be transferred pursuant to the Purchase Agreement prior to the date herein.
	 
	9.	 	This Agreement shall not be deemed, either expressly or impliedly, to waive, amend or
supplement any provision of the Affected Documents other than as set forth herein, each of
which Affected Document, as modified hereby, remains in full force and effect and is hereby
reaffirmed, ratified and confirmed.
	 
	10.	 	By its signature hereto each of the investors signing hereto as an Investor
(constituting all of the Investors in Series 2005-1) hereby direct the Indenture Trustee to
agree, consent to and accept this Agreement. For the purposes of the signature pages
hereto, the term “Investor” is synonymous with the term “Noteholder” as defined in the
Master Indenture.
	 
	11.	 	The Issuer represents and warrants that the Apple Ridge Funding, LLC Secured Variable
Funding Notes, Series 2005-1 (the “Series 2005-1 Notes”) are the only Notes
outstanding under the Master Indenture. Each Conduit Purchaser party hereto represents and
warrants that (i) it is the beneficial owner of the Series 2005-1 Notes currently
outstanding issued in its favor; (ii) it is duly authorized to consent to this Agreement
and to direct the Indenture Trustee as set forth herein; and (iii) its authorization has
not been granted or assigned to any other person or entity.

5

 

EXECUTION COPY

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their respective
officers thereunto duly authorized as of the date first above written.

	 	 	 	 	 
	 	CARTUS CORPORATION

 	 
	 	By:  	/s/ David M. Rapp
 	 
	 	 	Name:  	David M. Rapp    	 
	 	 	Title:  	Vice President 	 
	 
	 	CARTUS FINANCIAL CORPORATION

 	 
	 	By:  	/s/ David M. Rapp
 	 
	 	 	Name:  	David M. Rapp    	 
	 	 	Title:  	Vice President 	 
	 
	 	APPLE RIDGE SERVICES CORPORATION

 	 
	 	By:  	/s/ David M. Rapp
 	 
	 	 	Name:  	David M. Rapp    	 
	 	 	Title:  	Vice President 	 
	 
	 	APPLE RIDGE FUNDING LLC

 	 
	 	By:  	/s/ David M. Rapp
 	 
	 	 	Name:  	David M. Rapp    	 
	 	 	Title:  	Vice President 	 
	 

Signature Page to Fourth Omnibus Amendment

November 2006

S-1

 

	 	 	 	 	 
	 	THE BANK OF NEW YORK, as Successor Indenture Trustee and Paying Agent

 	 
	 	By:  	/s/ Gregory J. Weadock
 	 
	 	 	Name:  	Gregory J. Weadock    	 
	 	 	Title:  	Trust Officer 	 
	 

Signature Page to Fourth Omnibus Amendment

November 2006

S-2

 

	 	 	 	 	 
	 	 	CALYON CORPORATE AND INVESTMENT BANK, as
Administrative Agent and a Managing Agent
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Sam Pilcer
	 

	 	 	 	 
	 	 	Name: Sam Pilcer
	 	 	Title: Managing Director
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Gary Miller
	 

	 	 	 	 
	 	 	Name: Gary Miller
	 	 	Title: Managing Director
	 
	 	 	 	 
	 	 	CALYON NEW YORK BRANCH,

as a Committed Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Sam Pilcer
	 

	 	 	 	 
	 	 	Name: Sam Pilcer
	 	 	Title: Managing Director
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Gary Miller
	 

	 	 	 	 
	 	 	Name: Gary Miller
	 	 	Title: Managing Director
	 
	 	 	 	 
	 	 	ATLANTIC ASSET SECURITIZATION LLC, as a Conduit Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Sam Pilcer
	 

	 	 	 	 
	 	 	Name: Sam Pilcer
	 	 	Title: Managing Director
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Gary Miller
	 

	 	 	 	 
	 	 	Name: Gary Miller
	 	 	Title: Managing Director

Signature Page to Fourth Omnibus Amendment

November 2006

S-3

 

	 	 	 	 	 
	 	 	BMO CAPITAL MARKETS CORP., as a Managing Agent
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Brian T. Zaban
	 

	 	 	 	 
	 	 	Name: Brian T. Zaban
	 	 	Title: Vice President
	 
	 	 	 	 
	 	 	BANK OF MONTREAL, as a Committed Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Gary Herron
	 

	 	 	 	 
	 	 	Name: Gary Herron
	 	 	Title: Associate
	 
	 	 	 	 
	 	 	FAIRWAY FINANCE COMPANY, LLC,

as a Conduit Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Amy S. Keith
	 

	 	 	 	 
	 	 	Name: Amy S. Keith
	 	 	Title: Vice President

Signature Page to Fourth Omnibus Amendment

November 2006

S-4

 

	 	 	 	 	 
	 	 	THE BANK OF NOVA SCOTIA,
as a Managing Agent and a Committed Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Norman Last
	 

	 	 	 	 
	 	 	Name: Norman Last
	 	 	Title: Managing Director
	 
	 	 	 	 
	 	 	LIBERTY STREET FUNDING CORP.,
as a Conduit Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Jill A. Gordon
	 

	 	 	 	 
	 	 	Name: Jill A. Gordon
	 	 	Title: Vice President

Signature Page to Fourth Omnibus Amendment

November 2006

S-5

 

	 	 	 	 	 
	 	 	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., New York
Branch, as a Managing Agent
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Aditya Reddy
	 

	 	 	 	 
	 	 	Name: Aditya Reddy
	 	 	Title: VP
	 
	 	 	 	 
	 	 	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., New York
Branch, as a Committed Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Chi-Cheng Chen
	 

	 	 	 	 
	 	 	Name: Chi-Cheng Chen
	 	 	Title: Authorized Signatory
	 
	 	 	 	 
	 	 	VICTORY RECEIVABLES CORPORATION,

as a Conduit Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Franklin P. Collazo
	 

	 	 	 	 
	 	 	Name: Franklin P. Collazo
	 	 	Title Secretary

Signature Page to Fourth Omnibus Amendment

November 2006

S-6

 

	 	 	 	 	 
	 	 	SMBC SECURITIES, INC.,

as a Managing Agent
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Eric Zerof
	 

	 	 	 	 
	 	 	Name: Eric Zerof
	 	 	Title: President
	 
	 	 	 	 
	 	 	SUMITOMO MITSUI BANKING CORPORATION,

as a Committed Purchaser
	 
	 	 	 	 
	 

	 	By:
	 	/s/ Shigeru Tsuru
	 

	 	 	 	 
	 	 	Name: Shigeru Tsuru
	 	 	Title: Joint General Manager

	 	 	 	 	 	 	 
	 	 	MANHATTAN ASSET FUNDING COMPANY LLC,

as a Conduit Purchaser
	 
	 	 	 	 	 	 
	 	 	 	 	By: MAF Receivables Corp., its Member
	 
	 	 	 	 	 	 
	 

	 	 	 	By:
	 	/s/ Philip A. Martone
	 

	 	 	 	 	 	 
	 	 	 	 	Name: Philip A Martone
	 	 	 	 	Title: Vice President

Signature Page to Fourth Omnibus Amendment

November 2006

S-7EX-10.1

 

RESTATED EMPLOYMENT AGREEMENT

     THIS RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of November 29, 2006,
by and between BioScrip, Inc., formerly MIM Corporation, (the “Company”), and Richard H. Friedman
(“Executive”).

WHEREAS, the Company and Executive are parties to a certain Employment Agreement dated December 1,
1998 (the “Original Agreement”);

WHEREAS, the parties amended the Original Agreement on October 11, 1999, December 31, 2001, August
9, 2004, October 28, 2004, and June 13, 2006 in various particulars to reflect certain changed
circumstances to Executive’s employment; and

WHEREAS, the parties now wish to set forth in this Agreement all of the amended terms to the
Original Agreement and to restate the terms and conditions of Executive’s employment with the
Company.

NOW, THEREFORE, in consideration of the mutual covenants set forth herein and other valuable
consideration, the sufficiency of which is hereby acknowledged, the parties hereto, intending to be
legally bound, restate their agreement as follows:

     1. Term. Effective as of June 1, 2006 (the “Effective Date”), the Company hereby
agrees to employ Executive, and Executive hereby accepts such employment, for the period
retroactively commencing on the Effective Date and continuing through and including May 31, 2008,
as Chief Executive Officer, President and Chairman of the Board of Directors of the Company (the
“Board”) unless sooner terminated in accordance with the provisions of Section 4 or Section 5 (the
period during which the Executive is employed hereunder, including any extensions or renewals
thereof, being hereinafter referred to as the “Term”). In the event this Agreement is not renewed
upon expiration of the Term, such non-renewal shall be deemed a termination of Executive’s
employment without cause and Executive shall be entitled to receive the termination benefits set
forth in Section 5.2(b) of this Agreement.

     2. Duties and Location. Executive, in his capacity as Chief Executive Officer,
President and Chairman of the Board, shall faithfully perform for the Company the duties of said
office and position and such other duties of an executive, managerial, or administrative nature as
shall be specified and designated from time to time by the Board, to whom Executive shall directly
report. The Executive shall devote all of his business time and effort to the performance of his
duties hereunder, and shall be employed in Elmsford, New York, subject to travel from time
to time as deemed necessary or appropriate.

     3. Compensation.

     3.1 Salary. The Company shall pay Executive during the Term an initial base salary at
the rate of $737,811 per annum (the “Annual Salary”), in accordance with the

1

 

customary payroll practices of the Company applicable to senior executives, in installments
not less frequently than monthly.

     3.2 Benefits — In General. In accordance with policies applicable to all Company
employees with respect to benefits contribution, Executive shall be permitted during the Term to
participate in the group life, hospitalization or disability insurance plans, health programs,
pension and profit sharing plans, salary reviews, and similar benefits (other than bonuses and
stock options or other equity-based compensation, which are provided for under Section 3.3 and 3.4
hereof, or severance, displacement or other similar benefits) which are of a type available from
time to time to other senior executives of the Company generally, in each case to the extent that
the Executive is eligible under the terms of such plans or programs.

     3.3 Specific Benefits. During the Term, Executive shall be entitled to receive a
bonus each calendar year, payable in cash in accordance with, and subject to the terms and
conditions of the Company’s then applicable short- and long-term bonus or other incentive (each, a
“Bonus Program”). Compensation shall be set at a maximum of 60% (the “Maximum Bonus Percentage”)
of Executive’s Annual Salary payable subject to, and in accordance with the terms and provisions of
the Bonus Program and shall be payable within ten (10) days of the completion of the audited
financial results of the Company. The payment of all bonus payments made to Executive hereunder
shall be subject to the limitations set forth in Section 3.7 hereof.

     3.4 Grant of Option. In addition to all prior equity grants made to Executive,
Executive shall be entitled to receive on the first business day of each new year, subject to
applicable law (i) options (“Options”) to purchase 200,000 shares of the common stock, par value
$0.0001 per share, of the Company (“Common Stock”), under the Plan, at a price per share equal to
the closing stock price on the last trading day immediately prior to each January 1 during the Term
(subject to applicable law relating to incentive stock options in the case of grants thereof); or
(ii) subject to the terms and conditions of any applicable plan(s) and agreement(s), such number of
shares of restricted stock as determined by establishing the value of the Options as determined
under the Black-Sholes option valuation methodology using variables consistent with the Company’s
past practice, divided by the closing stock price for the Common Stock on the trading day
immediately prior to each January 1 during the Term. Options in excess of the number permitted to
receive ISO treatment under Section 422 of the Code shall not be qualified as ISO’s and shall be
treated as non-qualified stock options (“NQSO’s”). The Options shall be subject to the terms and
conditions of the Plan and any stock option agreement between the parties. After such grant,
Executive shall be eligible for additional grants of options, if any, as recommended by the
Company’s Compensation Committee.

     3.5 Vacation. Executive shall be entitled to vacation of 20 business days per
calendar year, to be accrued and available in accordance with the policies applicable to senior
executives of the Company generally.

2

 

     3.6 Expenses. The Company shall pay or reimburse Executive ordinary and reasonable
out-of-pocket expenses actually incurred (and, in the case of reimbursement, paid) by Executive
during the Term in the performance of Executive’s services under this Agreement, including, but not
limited to, business related travel and/or entertainment expenses; provided, that Executive submits
proof of such expenses, with the properly completed forms and supporting receipts and other
documentation as prescribed from time to time by the Company, in accordance with the policies
applicable to senior executives of the Company generally. The Company shall directly pay the
attorneys’ fees of Wechsler & Cohen, LLP, 17 State Street, 15th Floor, New York, New
York 10004, Tax Identification No. 13-3805383, up to a maximum of $10,000, incurred in connection
with the negotiation of this Agreement.

     3.7 Shareholder Approval. Notwithstanding any provision herein to the contrary, to
the extent that any compensation that would be payable to Executive hereunder (but for the
operation of this Section 3.7 would not be deductible for Federal tax purposes by the Company as a
result of the limitations of Section 162(m) of the Internal Revenue Code of 1986, as amended, as
determined by the Company’s tax counsel or independent public accountants (“nondeductible
compensation”), then such nondeductible compensation shall not be payable by the Company or paid by
the Company in the taxable year of the Company in which such payment otherwise would be required
(but for the operation of this Section 3.7) to be made under the Agreement or any other agreement
entered into between the Company and Executive to effectuate the provisions hereof, but, instead,
shall be deferred to and become payable in the next subsequent taxable year of the Company in which
such compensation would be deductible for Federal tax purposes by the Company taking into account
the limitations of Section 162(m).

     4. Termination upon Death or Disability.

     4.1 Termination upon Death. If Executive dies during the Term, the obligations of the
Company to or with respect to Executive shall terminate in their entirety except as otherwise
provide under this Section 4. Upon death, within thirty days: (i) the Executive’s estate or
beneficiaries shall be entitled to receive any Annual Salary and other benefits (including bonuses
awarded or declared but not yet paid) earned and accrued under Sections 3.1, 3.2 and/or 3.3 of this
Agreement prior to the date of termination and reimbursement for expenses incurred prior to the
date of termination as set forth in Section 3.6 hereof; (ii) the Executive’s estate or
beneficiaries shall be entitled to receive a pro rata bonus for the year in which such death
occurred; (iii) all unvested options shall immediately vest which, together with all fully vested
and exercisable Options granted under Section 3.4 hereof or elsewhere and held by Executive, may be
exercised by his estate for a period of one (1) year from and after the date of Executive’s death;
(iv) all unvested restricted stock granted to Executive shall immediately vest; (v) to the extent
possible, Executive’s beneficiaries and/or estate shall become vested in any pension or other
deferred compensation other than pension or deferred compensation under a plan intended to be
qualified under Section 401(a) or 403(a) of the Internal Revenue Code of 1986, as amended; and (vi)
Executive’s estate and beneficiaries shall

3

 

have no further rights to any other compensation or benefits hereunder on or after the
termination of employment, or any other rights hereunder.

Notwithstanding anything to the contrary contained in this Section 4.1, it is expressly understood
and agreed that nothing in the foregoing clause (iv) shall restrict the ability of the Company to
amend or terminate such benefits plans and programs from time to time in its sole and absolute
discretion; provided, however, that the Company shall in no event be required to provide any
coverage contemplated by Section 3.2 hereof after such time as Executive becomes entitled to
coverage under the benefit plans and programs of another employer or recipient of the Executive’s
services (and provided, further, that such entitlement shall be determined without regard to any
individual waivers or other arrangements).

     4.2 Termination upon Disability. If Executive by virtue of ill health or other
disability is unable to perform substantially and continuously the duties assigned to him for more
than 180 consecutive or non-consecutive calendar days out of any consecutive twelve-month period,
the Company shall have the right, to the extent permitted by law, to terminate the employment of
Executive upon notice in writing to Executive; provided that the Company will have no right to
terminate Executive’s employment if, in the opinion of a qualified physician reasonably acceptable
to the Company, it is reasonably certain that Executive will be able to resume Executive’s duties
on a regular full-time basis within 30 days of the date Executive receives notice of such
termination. Upon termination of employment by virtue of disability, within thirty days: (i) the
Executive shall be entitled to receive any Annual Salary and other benefits (including bonuses
awarded or declared but not yet paid) earned and accrued under Sections 3.1, 3.2 and/or 3.3 of this
Agreement prior to the date of termination and reimbursement for expenses incurred prior to the
date of termination as set forth in Section 3.6 hereof; (ii) the Executive shall receive a pro rata
bonus under Section 3.3 for the year in which such disability occurred; (iii) all unvested options
shall immediately vest which, together with all fully vested and exercisable Options granted under
Section 3.4 hereof or elsewhere and held by Executive, may be exercised by Executive for a period
of one (1) year from and after the date of Executive’s disability; (iv) all unvested restricted
stock granted to Executive shall immediately vest; (v) if Executive’s disabilities shall continue
for a period of six (6) months after his termination under this Section 4.2, Executive shall
receive for a period for two (2) years after termination of employment: (A) the Annual Salary that
Executive was receiving at the time of such termination of employment, less the gross proceeds paid
to Executive on account of Social Security or other similar benefits and Company provided long-term
disability insurance, payable in accordance with Section 3.2 hereof; and (B) such continuing
coverage under the benefit plans and programs Executive would have received under Section 3.2
hereof as would have applied in the absence of such termination; it being expressly understood and
agreed that nothing in this clause (v) shall restrict the ability of the Company to amend or
terminate such benefits plans and programs from time to time in its sole and absolute discretion;
provided, however, that the Company shall in no event be required to provide any coverage
contemplated in Section 3.2 hereof after such time as Executive becomes entitled to coverage under
the benefit plans and programs of another employer or

4

 

recipient of Executive’s services (and provided, further, that such entitlement shall be
determined without regard to any individual waivers or other arrangements); ; (v) to the extent
possible, Executive’s beneficiaries and/or estate shall become vested in any pension or other
deferred compensation other than pension or deferred compensation under a plan intended to be
qualified under Section 401(a) or 403(a) of the Internal Revenue Code of 1986, as amended; and
(vii) Executive shall have no further rights to any other compensation or benefits hereunder on or
after the termination of employment, or any other rights hereunder.

     5. Certain Terminations of Employment.

     5.1 Termination for “Cause;” Termination of Employment by Executive Without
Good Reason.

     (a) For purposes of this Agreement, “Cause” shall mean: (i) Executive’s conviction of
a felony or a crime of moral turpitude; (ii) Executive’s material violation of Executive’s
primary duties or responsibilities to the Company which constitute willful misconduct or
willful dereliction of duty, or the material breach of the covenants contained in Section 6
hereof; or (iii) Executive’s other material breach of this Agreement which breach shall
have continued unremedied for ten (10) days after written notice by the Company to
Executive specifying such material breach.

     (b) The Company may terminate Executives employment hereunder for Cause. If the
Company terminates the Executive for Cause, within thirty days: (i) the Executive shall
receive Annual Salary and other benefits (including bonuses awarded or declared but not yet
paid) earned and accrued under this Agreement prior to the effective date of the
termination of employment (and reimbursement for expenses incurred prior to the effective
date of the termination of employment as set forth in Section 3.6); (ii) all vested and
unvested options shall lapse and terminate immediately and may no longer be exercised;
(iii) all unvested restricted stock shall be forfeited; and (iv) the Executive shall have
no further rights to any other compensation or benefits hereunder on or after the
termination of employment, or any other rights hereunder.

     (c) Executive may terminate his employment upon written notice to the Company which
specifies an effective date of termination not less than 30 days from the date of such
notice. If Executive terminates his employment and the termination is not covered by
Section 4, 5.2, or 5.3: (i) Executive shall receive Annual Salary and other benefits
(including bonuses awarded or declared but not yet paid) earned and accrued under this
Agreement prior to the effective date of the termination of employment (and reimbursement
for expenses incurred prior to the effective date of the termination of employment as set
forth in Section 3.6); (ii) all fully vested and exercisable options granted under Section
3.4 hereof and held by Executive may be exercised by Executive for a period of 30 days from
and after the date of Executive’s effective date of termination; (iii) all unvested

5

 

restricted stock shall be forfeited; and (iv) Executive shall have no further rights
to any compensation or other benefits hereunder on or after the termination of employment,
or any other rights hereunder.

     5.2 Termination Without Cause; Termination for Good Reason.

     (a) For purposes of this Agreement, “Good Reason” shall mean the existence of any one
or more of the following conditions that shall continue for more than 30 days following
written notice thereof by Executive to the Company:

     (i) the material reduction of or change in
Executive’s reporting lines, title(s), authority, duties or
responsibilities, or the assignment to Executive of duties materially
inconsistent with Executive’s position or positions with the Company;

     (ii) the relocation of Executive’s more than 50
miles from its current location, unless such relocation was with your
consent;

     (iii) the reduction in Executive’s Annual Salary
or the Maximum Bonus Percentage (it being acknowledged and agreed
that the Maximum Bonus Percentage is 60% and that the achievement or
failure to achieve personal and/or corporate goals may decrease
Executive’s bonus achieved in any year and that such failure to
achieve the maximum shall not be deemed to be “Good Reason”
hereunder); or

     (iv) the Company’s material and continuing
breach of this Agreement.

     (b) The Company may terminate Executive’s employment at any time for any reason
whatsoever. If the Company terminates Executive’s employment without Cause (and/or the
termination is not covered by Section 4, 5.1 or 5.3 hereof), within thirty days: (i)
Executive shall receive Annual Salary and other benefits (including bonuses awarded but not
yet paid) earned and accrued under this Agreement prior to the effective date of the
termination of employment (and reimbursement for expenses incurred prior to the effective
date of the termination of employment as set forth in Section 3.6); (ii) the Executive
shall receive a pro rata bonus for the year in which such termination occurred; (iii) all
unvested options shall immediately vest which, together with all fully vested and
exercisable Options granted under Section 3.4 hereof or elsewhere and held by Executive,
may be exercised by Executive for a period of one (1) year from and after the date of
Executive’s termination; (iv) all unvested restricted stock granted to Executive shall
immediately vest; (v) Executive shall receive: (A) for the

6

 

longer of (x) two (2) years after termination of employment or (y) the period of time
remaining under the Term, the Annual Salary that Executive was receiving at the time of
such termination of employment, payable in accordance with Section 3.1 hereof; and (B) for
a period of two (2) years after termination of employment, such continuing coverage under
the benefit plans and programs Executive would have received under Section 3.2 hereof as
would have applied in the absence of such termination, it being expressly understood and
agreed that nothing in this clause (v) shall restrict the ability of the Company to amend
or terminate such benefits plans and programs from time to time in its sole and absolute
discretion; provided, however, that the Company shall in no event be required to provide
any coverage contemplated by Section 3.2 hereof after such time as Executive becomes
entitled to coverage under the benefit plans and programs of another employer or recipient
of Executive’s services (and provided, further, that such entitlement shall be determined
without regard to any individual waivers or other arrangements); (vi) Executive shall
become vested in any pension or other deferred compensation other than pension or deferred
compensation under a plan intended to be qualified under Section 401(a) or 403(a) of the
Internal Revenue Code of 1986, as amended; and (vii) Executive shall have no further rights
to any other compensation or benefits hereunder on or after the termination of employment,
or any other rights hereunder.

     (c) Executive may terminate Executive’s employment with the Company for “Good
Reason.” If Executive terminates his employment for Good Reason, within thirty days: (i)
Executive shall receive Annual Salary and other benefits (including bonuses awarded but not
yet paid) earned and accrued under this Agreement prior to the effective date of the
termination of employment (and reimbursement for expenses incurred prior to the effective
date of the termination of employment as set forth in Section 3.6; (ii) the Executive shall
receive a pro rata bonus for the year in which such termination occurred; (iii) all
unvested options shall immediately vest which, together with all fully vested and
exercisable Options granted under Section 3.4 hereof or elsewhere and held by Executive,
may be exercised by Executive for a period of one (1) year from and after the date of
Executive’s termination; (iv) all unvested restricted stock granted to Executive shall
immediately vest; (v) Executive shall receive: (A) for the longer of (x) two (2) years
after termination of employment or (y) the period of time remaining under the Term, the
Annual Salary that Executive was receiving at the time of such termination of employment,
payable in accordance with Section 3.1 hereof; and (B) for a period of two (2) years after
termination of employment, such continuing coverage under the benefit plans and programs
Executive would have received under Section 3.2 hereof as would have applied in the absence
of such termination, it being expressly understood and agreed that nothing in this clause
(v) shall restrict the ability of the Company to amend or terminate such benefits plans and
programs from time to time in its sole and absolute discretion; provided, however, that the
Company shall in no event be required to provide any coverage contemplated by Section 3.2
hereof after such time as Executive becomes entitled to coverage under the benefit plans
and programs of another

7

 

employer or recipient of Executive’s services (and provided, further, that such
entitlement shall be determined without regard to any individual waivers or other
arrangements); (vi) Executive shall become vested in any pension or other deferred
compensation other than pension or deferred compensation under a plan intended to be
qualified under Section 401(a) or 403(a) of the Internal Revenue Code of 1986, as amended;
and (vii) Executive shall have no further rights to any other compensation or benefits
hereunder on or after the termination of employment, or any other rights hereunder.

     5.3 Certain Terminations after Change of Control.

     (a) For purposes of this Agreement, “Change of Control” means the occurrence of one
or more of the following: (i) a “person” or “group” within the means the meaning of
sections 13(d) and 14(d) of the Securities and Exchange Act of 1934 (the “Exchange Act”)
other than the Executive, becomes the “beneficial owner” (within the meaning of Rule l3d-3
under the Exchange Act) of securities of the Company (including options, warrants, rights
and convertible and exchangeable securities) representing 30% or more of the combined
voting power of the Company’s then outstanding securities in any one or more transactions
unless approved by at least two-thirds of the Board of Directors then serving at that time;
provided, however, that purchases by employee benefit plans of the Company and by the
Company or its affiliates shall be disregarded; or (ii) any sale, lease, exchange or other
transfer (in one transaction or a series of related transactions) of all, or substantially
all, of the operating assets of the Company; or (iii) a merger or consolidation, or a
transaction having a similar effect, where (A) the Company is not the surviving
corporation, (B) the majority of the Common Stock of the Company is no longer held by the
stockholders of the Company immediately prior to the transaction, or (C) the Company’s
Common Stock is converted into cash, securities or other property (other than the common
stock of a company into which the Company is merged), unless such merger, consolidation or
similar transaction is with a subsidiary of the Company or with another company, a majority
of whose outstanding capital stock is owned by the same persons or entities who own a
majority of the Company’s Common Stock at such time; or (iv) at any annual or special
meeting of stockholders of the Company at which a quorum is present (or any adjournments or
postponements thereof), or by written consent in lieu thereof, directors (each a “New
Director” and collectively the “New Directors”) then constituting a majority of the
Company’s Board of Directors shall be duly elected to serve as New Directors and such New
Directors shall have been elected by stockholders of the Company who shall be an (I)
“Adverse Person(s)”; (II) “Acquiring Person(s)”; or (III) “40% Person(s)” (as each of the
terms set forth in (I), (II), and (III) hereof are defined in that certain Rights
Agreement, dated November 24, 1998, between the Company and American Stock Transfer & Trust
Company, as Rights Agent.

8

 

     (b) If within the one (1) year period commencing upon any Change of Control,
Executive is terminated by the Company or a successor entity and the termination is not
covered by Section 4 or 5. 1, or, within such one (1) year period, Executive elects to
terminate his employment after the Company or a successor entity materially reduces or
changes Executive’s reporting lines, title(s), authority, duties or responsibilities,
relocates Executive, or assigns Executive duties materially inconsistent with Executive’s
position or positions with the Company or a successor entity immediately prior to such
Change of Control: (i) Executive shall receive Annual Salary and other benefits (including
bonuses awarded or declared but not yet paid) earned and accrued under this Agreement prior
to the effective date of the termination of employment (and reimbursement for expenses
incurred prior to the effective date of the termination of employment as set forth in
Section 3.6); (ii) the Executive shall receive a pro rata bonus for the year in which such
termination occurred; (iii) all unvested options shall immediately vest which, together
with all fully vested and exercisable Options granted under Section 3.4 hereof or elsewhere
and held by Executive, may be exercised by Executive for a period of one (1) year from and
after the date of Executive’s termination; (iv) all unvested restricted stock granted to
Executive shall immediately vest; (v) Executive shall receive (A) for the longer of (x)
three (3) years after termination of employment; or (y) the period of time remaining under
the Term, the Annual Salary that Executive was receiving at the time of such termination of
employment, payable in accordance with Section 3.1 hereof, and (B) such continuing coverage
under the benefit plans and programs Executive would have received under Sections 3.2 of
this Agreement as would have applied in the absence of such termination; it being expressly
understood and agreed that nothing in this clause (v) shall restrict the ability of the
Company to amend or terminate such plans and programs from time to time in its sole and
absolute discretion; provided, however, that the Company shall in no event be required to
provide any coverage under Section 3.2 hereof after such time as Executive becomes entitled
to coverage under the benefit plans and programs of another employer or recipient of
Executive’s services (and provided, further, that such entitlement shall be determined
without regard to any individual waivers or other arrangements); (vi) to the extent
possible, Executive’s beneficiaries and/or estate shall become vested in any pension or
other deferred compensation other than pension or deferred compensation under a plan
intended to be qualified under Section 401(a) or 403(a) of the Internal Revenue Code of
1986, as amended; and (vii) Executive shall have no further rights to any other
compensation or benefits hereunder on or after the termination of employment or any other
rights hereunder.

     6. Covenants of Executive.

     6.1 Covenant Against Competition, Other Covenants. Executive acknowledges that: (i)
the principal business of the Company (which, for purposes of this Section 6 shall include the
Company and each of its subsidiaries and affiliates) is the
provision of a broad range of services designed to promote the cost-effective delivery of

9

 

pharmacy benefits, including pharmacy benefit management services, claims processing and/or the
purchasing of pharmaceutical products on behalf of pharmacy networks and long term care facilities
(including assisted living facilities and nursing homes) (such business, and any and all other
businesses that after the date hereof, and from time to time during the Term, become material with
respect to the Company’s then-overall business, herein being collectively refereed to as the
“Business”); (ii) the Company is dependent on the efforts of a certain limited number of persons
who have developed, or will be responsible for developing the Company’s Business, (iii) the
Company’s Business is national in scope; (iv) Executive’s work for the Company has given and will
continue to give him access to confidential affairs and proprietary information of the Company; (v)
the covenants and agreements of Executive contained in this Section 6 are essential to the business
and goodwill of the Company; and (vi) the Company would not have entered into this Agreement but
for the covenants and agreements set forth in this Section 6. Accordingly, Executive covenants and
agrees that:

     (a) So long as the Company has not breached this Agreement, at any time during his
employment with the Company and ending one (1) year following: (i) termination of
Executive’s employment with the Company (irrespective of the reason for such termination);
or (ii) payment of any Annual Salary in accordance with Section 4 or 5 hereof (unless such
termination is by the Company without Cause), whichever occurs last, Executive shall not
engage, directly or indirectly (which includes, without limitation owning, managing
operating, controlling, being employed by, giving financial assistance to, participating in
or being connected in any material way with any person or entity other than the Company),
anywhere in the United States in: (A) the Business or (B) any material component of the
Business; provided, however, that Executive’s ownership as a passive investor of less than
two percent (2%) of the issued and outstanding stock of a publicly held corporation shall
not be deemed to constitute competition.

     (b) During and after the period during which Executive is employed, Executive shall
keep secret and retain in strictest confidence, and shall not use for his benefit or the
benefit of others, except in connection with the business and affairs of the Company, all
confidential matters relating to the Company and/or the Company’s Business, learned by
Executive heretofore or hereafter directly or indirectly from the Company (the
“Confidential Company Information”), including, without limitation, information with
respect to: (i) the strategic plans, budgets, forecasts, intended expansion of product,
service or geographic markets of the company and it’s affiliates; (ii) sales figures,
contracts agreements, and undertakings with or with respect to the Company’s customers or
prospective customers; (iii) profit or loss figures; and (iv) then existing or then
prospective customers, clients, suppliers and sources of supply and customer lists, and
shall not disclose such Confidential Company Information to anyone outside of the Company
except with the Company’s express written consent and except for Confidential Company
Information which is at the time of receipt or thereafter becomes publicly known through no
wrongful act of Executive or is received
from a third party not under an obligation to keep such information confidential

10

 

and without breach of this Agreement. Notwithstanding the foregoing, this Section 6.1(b) shall
not apply to the extent that Executive is acting to the extent necessary to comply with
legal process; provided that in the event that the Executive is subpoenaed to testify or to
produce any information or documents before any court, administrative agency or other
tribunal relating to any aspect pertaining to the Company, he shall immediately notify the
Company thereof.

     (c) During the period commencing on the date hereof and ending two (2) years
following the later to occur of dates upon which Executive shall cease to be an (i)
employee or (ii) an “affiliate,” as defined in Rule 144 promulgated under the Securities
Act of 1993, and the rules and regulations promulgated thereunder (as amended, the “1993
Act”), of the Company, Executive shall not, without the Company’s prior written consent,
directly or indirectly, solicit or encourage to leave the employment or other service of
the Company any employee or independent contractor thereof or hire (on behalf of Executive
or any other person, firm, corporation or entity) any employee or independent contractor
who has voluntarily left the employment or other service of the Company within one (1) year
of the termination of such employee’s or independent contractor’s employment or other
service with the Company. During such a one (1) year period, Executive will not, whether
for his own account or for the account of any other person, firm, corporation or other
entity, intentionally interfere with the Company’s relationship with, or endeavor to entice
away from the Company any person who during the Term is or was a customer or client of the
Company.

     (d) All memoranda, notes, lists, records, property and any other tangible product and
documents (and all copies thereof) made, produced or compiled by Executive or made
available to Executive concerning the Business of the Company, including all Confidential
Company Information, shall be the Company’s property and shall be delivered to the Company
at any time on request.

     6.2 Rights and Remedies upon Breach.

     (a) Executive acknowledges and agrees that any breach by him of any of the provisions
of Section 6.1 hereof (the “Restrictive Covenants”) would result in irreparable injury and
damage for which money damages would not provide an adequate remedy. Therefore, if
Executive breaches or threatens to commit a breach of any of the provisions of Section 6.1
hereof, the Company shall have the ability to seek the following rights and remedies, each
of which rights and remedies shall be independent of the other and severally enforceable,
and all of which rights and remedies shall be in addition to, and not in lieu of, any other
rights and remedies available to the Company under law or in equity (including, without
limitation, the recovery of damages):

     (i) The right and remedy to have the Restrictive Covenants specifically
enforced (without posting bond and without the need to prove

11

 

damages) by any court
having equity jurisdiction, including, without limitation, the right to an entry
against Executive of restraining orders and injunctions (preliminary, mandatory,
temporary and permanent) against violations, threatened or actual, and whether or
not then continuing, of such covenants.

     (ii) The right and remedy to require Executive to account for and pay over to
the Company all compensation, profits, monies, accruals, increments or other
benefits (collectively, “Benefits”) derived or received by him as the result of any
transactions constituting a breach of the Restrictive Covenants, and Executive
shall account for and pay over such Benefits to the Company and, if applicable, its
affected subsidiaries and/or affiliates.

     (b) Executive agrees that in any action seeking specific performance or other
equitable relief, he will not assert or contend that any of the provisions of this Section
6 are unreasonable or otherwise unenforceable. The existence of any claim or cause of
action by Executive, whether predicated on this Agreement or otherwise, shall not
constitute a defense to the enforcement of the Restrictive Covenants.

     7. Other Provisions.

     7.1 Severability. Executive acknowledges and agrees that: (i) he has had an
opportunity to seek advice of counsel in connection with this Agreement; and (ii) the Restrictive
Covenants are reasonable in geographical and temporal scope and in all other respects. If it is
determined that any of the provisions of this Agreement, including, without limitation, any of the
Restrictive Covenants, or any part thereof, is invalid or unenforceable, the remainder of the
provisions of this Agreement shall not thereby be affected and shall be given full effect, without
regard to the invalid portions thereof.

     7.2 Duration and Scope of Covenants. If any court or other decision-maker of
competent jurisdiction determines that any of Executive’s covenants contained in this Agreement,
including, without limitation, any of the Restrictive Covenants, or any part thereof, is
unenforceable because of the duration or geographical scope of such provision, then, after such
determination has become final and unappealable, the duration or scope of such provision, as the
case may be, shall be reduced so that such provision becomes enforceable and, in its reduced form,
such provision shall then be enforceable and shall be enforced.

     7.3 Enforceability; Jurisdictions. Any controversy or claim arising out of or
relating to this Agreement or the breach of this Agreement that is not resolved by Executive and
the Company (or its subsidiaries or affiliates, where applicable), other than those arising under
Section 6 thereof, to the extent necessary for the Company (or its
subsidiaries or affiliates, where applicable) to avail itself of the rights and remedies
provided under Section 6.2 hereof, shall be submitted to arbitration in New York, New

12

 

York in accordance with New York law and the procedures of the American Arbitration Association. The
determination of the arbitrator(s) shall be conclusive and binding on the Company (or its
subsidiaries or affiliates, where applicable) and Executive and judgment may be entered on the
arbitrator(s)’ award in any court having jurisdiction.

     7.4 Notices. Any notice or other communication required or permitted hereunder shall
be in writing and shall be delivered personally, telegraphed, telexed, sent by facsimile
transmission or sent by certified, registered or express mail, postage prepaid. Any such notice
shall be deemed given when so delivered personally, telegraphed, telexed or sent by facsimile
transmission or, if mailed, five days after the date of deposit in the United States mails as
follows:

(i) If to the Company, to:

BioScrip, Inc.

100 Clearbrook Road

Elmsford, New York 10523

914-460-1661

Attention: General Counsel

with a copy to:

King & Spalding LLP

1185 Avenue of the Americas

New York, New York 10036-4003

Fax: (212) 556-2222

Attention: Richard A. Cirillo

(ii) If to the Executive, to:

Richard H. Friedman

82 North Chatsworth Avenue

Larchmont, NY 10538

with a copy to:

Wechsler & Cohen LLP

17 State Street

15th Floor

New York, New York 10004

Fax: (212) 847-7955

Attention: David B. Wechsler, Esq.

13

 

Any such person may by notice given in accordance with this Section 7.4 to the other parties hereto
designate another address or person for receipt by such person of notices hereunder.

     7.5 Entire Agreement. Except as otherwise indicated, this Agreement contains the
entire agreement between the parties with respect to the subject matter hereof and supersedes all
prior agreements, written or oral, with respect thereto.

     7.6 Waivers and Amendments. This Agreement may be amended, superseded, canceled,
renewed or extended, and the terms hereof may be waived, only by a written instrument signed by the
parties or, in the case of a waiver, by the party waiving compliance. No delay on the part of any
party in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor
shall any waiver on the part of any party of any such right, power or privilege nor any single or
partial exercise of any such right, power or privilege, preclude any other or further exercise
thereof or the exercise of any other such right, power or privilege.

     7.7 Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPALS OF CONFLICTS OF LAW.

     7.8 Assignment. This Agreement, and Executive’s rights and obligations hereunder, may
not be assigned by Executive and any purported assignment by Executive in violation hereof shall be
null and void. In the event of any sale, transfer or other disposition of all or substantially all
of the Company’s assets or business, whether by merger, consolidation or otherwise, the Company
(without limiting the Executive’s rights under Section 5.3) may assign this Agreement and its
rights hereunder.

     7.9 Withholding. The Company shall be entitled to withhold from any payments or
deemed payments any amount of tax withholding required by law, but with respect to bonus
compensation shall only withhold federal taxes at the bonus, or supplemental rate, to the extent
permitted by law.

     7.10 Binding Effect. This Agreement shall be binding upon and inure to the benefit of
the parties and their respective successors, permitted assigns, heirs, executors and legal
representatives.

     7.11 Counterparts. This Agreement may be executed by the parties hereto in separate
counterparts, each of which when so executed and delivered shall be an original but all such
counterparts together shall constitute one and the same instrument. Each counterpart may consist
of two copies hereof each signed by one of the parties hereto.

     7.12 Survival. Anything contained in this Agreement to the contrary not withstanding,
the provisions of Sections 5, 6, 7.3 and 7.9, and the other provisions of this Section 7 (to the
extent necessary to effectuate the survival of Sections 5, 6, 7.3 and 7.9),

14

 

shall survive termination of this Agreement and any termination of Executive’s employment
hereunder.

     7.13 Existing Agreements. Executive represents to the Company that he is not subject
or a party to any employment or consulting agreement, non-competition covenant or other agreement,
covenant or understanding which might prohibit him from executing this Agreement or limit his
ability to fulfill his responsibilities hereunder.

     7.14 Headings. The headings in this Agreement are for reference only and shall not
affect the interpretation of this Agreement.

     7.15 Mitigation. The Executive shall have no duty to mitigate, and any compensation
he may earn from a subsequent employer or entity shall not act as an offset against the Company’s
obligations to Executive under thus Agreement.

IN WITNESS WHEREOF, the parties hereto have signed their names as of the day and year first above
written.

	 	 	 	 	 	 
	EXECUTIVE: 	 	THE COMPANY:

BIOSCRIP, INC.

 	 
	 	 	By:  	 	 
	Richard H. Friedman 	 	 	Barry A. Posner 	 
	 	 	 	EVP & General Counsel 	 
	 

15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]